Loading provider…
Loading provider…
Neurological Surgery Physician in Stanford, CA
NPI: 1225218043Primary Practice Location
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA
Primary Employer
Stanford Hospital
stanfordhealthcare.org
HQ Phone
Get MD Gordon's Phone Numberphone_androidMobile
Get MD Gordon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2027
HI State Medical License
2022 - 2026
NV State Medical License
2022 - 2025
OR State Medical License
2021 - 2025
AK State Medical License
2021 - 2024
FL State Medical License
2021 - 2023

American Board of Neurological Surgery
Neurological Surgery
Stanford Health Care-Sponsored Stanford University
Internship • Surgery
2004 - 2005
Chief Residency • Neurological Surgery
2010 - 2011
Residency • Neurological Surgery
2005 - 2011
University of California
Research Associate • 1999 - 2000
1999 - 2000
2000 - 2002
2000 - 2002
Brown University
Research Associate • Neuroscience
1995 - 1999
Stanford University School Of Medicine
med.stanford.edu
2007 - 2009
2007 - 2009
UC Davis School of Medicine
health.ucdavis.edu
Medical School
Until 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 103 | 130 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 39 | 52 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 37 | 40 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 29 | 29 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 22 | 22 |
Development of an EGFRvIII specific recombinant antibody
Lead Sponsor: Stanford University
Collaborators: National Institutes of Health (NIH), National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Panitumumab, DRUG: Panitumumab-IRDye800, PROCEDURE: Near-Infrared Fluorescence Imaging, DEVICE: POINPOINT-IR9000
Lead Sponsor: Eben Rosenthal
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: Cetuximab, DRUG: Cetuximab-IRDye 800CW, PROCEDURE: Tumor resection
Lead Sponsor: Celldex Therapeutics
Intervention / Treatment: DRUG: Bevacizumab, DRUG: KLH, DRUG: Rindopepimut (CDX-110) with GM-CSF